ACEVION-MR

ASTRAVION PHARMACEUTICALS presents ACEVION-MR, a powerful combination of Aceclofenac, Paracetamol, and Chlorzoxazone designed for the management of painful musculoskeletal disorders. Aceclofenac acts as a non-steroidal anti-inflammatory drug (NSAID) that helps reduce pain and inflammation, while Paracetamol enhances pain relief and helps control fever. Chlorzoxazone functions as a muscle relaxant, relieving muscle stiffness and spasms.

This triple-action formula is commonly prescribed for conditions such as muscle strains, sprains, back pain, cervical and lumbar spondylosis, sports injuries, and other musculoskeletal disorders where pain and muscle spasm occur together. Manufactured under stringent quality standards, ACEVION-MR delivers effective symptom relief and promotes patient comfort.

Specifications

Product Name: ACEVION-MR
Generic Name/Composition: Aceclofenac, Paracetamol & Chlorzoxazone Tablets
Dosage Form: Tablet
Category: Analgesic, Anti-inflammatory & Muscle Relaxant
Indication: Muscle spasms, musculoskeletal pain, back pain, sprains, strains, sports injuries, and inflammatory conditions affecting muscles and joints
Route of Administration: Oral
Storage Conditions: Store in a cool, dry place away from direct sunlight and moisture.
Manufacturer/Marketer: ASTRAVION PHARMACEUTICALS LLP

Overview

ACEVION-MR is a combination medication from ASTRAVION PHARMACEUTICALS formulated to provide effective relief from pain, inflammation, and muscle spasms associated with various musculoskeletal conditions. Combining the therapeutic benefits of Aceclofenac, Paracetamol, and Chlorzoxazone, this formulation helps improve mobility, reduce discomfort, and support faster recovery from muscle-related ailments.

Key Benefits

Provides effective relief from pain and inflammation.
Helps reduce muscle stiffness and spasms.
Improves mobility and physical comfort.
Supports recovery from musculoskeletal injuries and conditions.
Combines analgesic, anti-inflammatory, and muscle relaxant properties in a single tablet.

Page updated

Google Sites

Report abuse